Innovation NJ’s weekly update spotlights the selection of Rutgers as the site of COVID-19 vaccine trials and a number of upcoming science and technology news and events happening around New Jersey. Princeton Innovation Center BioLabs – Virtual Event: Take Your Idea to Market InnovationNJ Members are cordially invited to the Princeton Innovation Center BioLabs for […]
Innovation NJ
Innovation NJ: Women Who Tech Wants Women Startups to Solve Coronavirus Problems
Innovative Women-Led Startups Eligible for Grants via the Women Who Tech COVID-19 Tech Challenge In the face of one of our country’s greatest public health challenges in over a century, all sectors of America’s economy and strata of society are being called upon to act. Now Women Who Tech, the organization focusing on the lack […]
New Evidence Shows R&D Tax Credits Promote Private Research
New Evidence That the R&D Tax Credit Promotes Research, Especially in Small Companies According to Joe Kennedy, “The American Economic Association just published yet another study showing that research and development tax credits are effective in spurring more research by private companies, especially smaller ones. Although large companies conduct most private research, small companies are […]
Innovation NJ: Using Blood Plasma to Treat COVID-19 Patients
Rutgers, University Hospital Lead Way in Treating COVID-19 with Convalescent Plasma from Recovered PatientsĀ Rutgers physicians and University Hospital are leading the way in using blood plasma from patients who recovered from COVID-19 to treat new patients who are severely ill with COVID-19 infections. The clinicians and hospital are calling for more blood donations from those […]
Innovation NJ: Rutgers Saliva Test for Coronavirus Gets FDA Approval
New Rutgers Saliva Test for Coronavirus Gets FDA Approval The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. […]